The FOPH shall operate an information system to process data under Article 8b .
Doctors who treat persons with medicinal cannabis products must record the data required for data collection under Article 8b . Data on patients must be recorded in pseudonymised form.
The Federal Council shall specify:
the data required for data collection under Article 8b , in particular on side effects;
the frequency and time of data collection;
the doctors’ rights of access in accordance with paragraph 2;
the technical and organisational aspects of the data collection system;
the retention periods for the data;
the publication of the statistical analyses.
It may stipulate that data need no longer be recorded if new data is no longer required for the scientific evaluation under Article 8b paragraph 2.
0 commentaries
No commentaries are available for this article yet.